Choroidal and Retinal Thickness Following Strabismus Surgery
Effect of Strabismus Surgery on Macular and Subfoveal Choroidal Thickness Assessed by Spectral Domain Optical Coherence Tomography
1 other identifier
observational
30
1 country
1
Brief Summary
Prospective study, conducted at Tanta University Ophthalmology Department Measurement of macular and choroidal thickness before and after strabismus surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2020
CompletedFirst Submitted
Initial submission to the registry
February 23, 2020
CompletedFirst Posted
Study publicly available on registry
February 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFebruary 26, 2020
February 1, 2020
10 months
February 23, 2020
February 23, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Choroidal and retinal thickness change after strabismus surgery
Measured by Spectral Domain Optical coherence tomography
preoperative, 1st week, 1st month, and 3 months
Study Arms (3)
Horizontal muscle surgery
Patients suffering from esotropia or exotropia, will have medial/lateral rectus recession/resection
Patients with Inferior Oblique Overaction
Will undergo inferior Oblique Myectomy
Patients with combined horizontal and oblique muscle surgery
Having combined surgery
Interventions
Resection or recession of the medial or lateral rectus muscle, or inferior oblique myectomy
Eligibility Criteria
All individual with strabismus fulfilling the inclusion criteria
You may qualify if:
- No prior history of ocular surgery or trauma
- Normal ocular examination findings
- No medical or family history of retinal disease, glaucoma or diabetes mellitus.
You may not qualify if:
- Patients with orbital and/or craniofacial abnormalities
- Patients with sensory or restrictive strabismus or neurological disease
- Preoperative retinal or macular pathology
- Patient who is unable to cooperate to do OCT scanning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University Hospital
Tanta, Gharbia Governorate, 31111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharif Y El Emam, MD
Tanta University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
February 23, 2020
First Posted
February 26, 2020
Study Start
February 15, 2020
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
February 26, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share